Patent exhaustion determines when an authorized sale ends a patent owner's rights over the particular item sold. It affects buyers, resellers, manufacturers, licensees, and patent owners structuring product transactions.

Flat illustration of a boxed product passing through an open gate with a snapped tether to represent patent exhaustion after an authorized sale.

Key Takeaways

  • An authorized sale generally exhausts patent rights in the particular item sold.
  • The buyer may usually use, resell, repair, or modify that item, but may not make new copies of the patented invention.
  • Exhaustion can cover method claims and components that substantially embody a patented invention.
  • Post-sale restrictions generally do not preserve patent infringement claims, although contractual obligations may remain.
  • An authorized foreign sale can exhaust U.S. patent rights under Impression Products v. Lexmark.
  • Patent exhaustion affects sold items, while patent expiration affects the patent itself.

What Is Patent Exhaustion and When Does It Apply?

The patent exhaustion definition centers on an authorized sale. When a patent owner sells a patented item, or authorizes someone else to sell it, the owner's patent rights in that particular item are generally exhausted. Patent law ordinarily cannot then be used to control the item's later use or resale.

This principle is sometimes called the first sale doctrine for patents. It resembles, but is not identical to, the first sale doctrine in copyright and trademark law. Patent exhaustion is a court-developed doctrine rather than a rule that transfers ownership of the patent. The patent owner keeps the patent and may continue enforcing it against unauthorized manufacturers and sellers of other infringing items.

Three questions usually determine whether the doctrine applies:

  1. Was there a sale? A transfer labeled a license may require closer review to determine what rights and property actually changed hands.
  2. Was the sale authorized? A sale by the patent owner is normally authorized. A licensee's sale may be authorized only if it falls within the licensee's authority.
  3. Does the asserted patent cover the sold item? Exhaustion may apply even when the item does not contain every claimed feature, provided it substantially embodies the patented invention.

The doctrine often arises as a defense to patent infringement. Its application is fact-sensitive. Courts examine the patent claims, the seller's authority, the transaction documents, the product's characteristics, and the buyer's conduct rather than relying only on labels such as "sale," "license," or "single use."

First Sale Doctrine: Reselling, Repairing, and Modifying Items

After an authorized sale, the buyer generally owns the physical item free from further control under the seller's patent rights. The buyer can ordinarily use it, lend it, give it away, or resell it. A reseller can therefore sell a genuine patented product without obtaining a new patent license for that specific item.

Exhaustion also permits many repairs and modifications. Replacing worn components, restoring an item to working condition, or refurbishing it for resale may fall within the right to use the sold property. The dividing line is reconstruction. A buyer may repair the purchased article, but patent exhaustion does not authorize the buyer to manufacture the patented invention anew or produce additional copies.

That distinction can become difficult when refurbishment replaces several parts or changes how the item operates. Relevant facts may include how much of the original item remains, which components embody the patented features, and whether the work preserves the sold article or effectively creates another patented article. Calling the activity "repair" does not settle the issue.

Exhaustion also does not create a right to cancel the original purchase, demand a refund, or disregard unrelated sales terms. Those questions arise under contract and consumer law. For example, the rules governing a three-day right to cancel a purchase are separate from the patent first sale doctrine.

If you are asking, "Can I sell them?" the starting answer is generally yes for genuine items acquired through an authorized sale. The answer may change if the products were made without permission, the seller exceeded a manufacturing license, or the resale operation creates new patented articles instead of transferring the original goods.

Products That Substantially Embody Patent Claims

A product does not always need to contain every limitation of a patent claim at the moment of sale for exhaustion to apply. Under Quanta Computer, Inc. v. LG Electronics, Inc., an authorized sale may exhaust patent rights when the sold product substantially embodies the patent.

The analysis asks whether the product includes the invention's essential features and has a reasonable noninfringing use. If the only remaining steps involve adding standard components or performing conventional activity, the product may substantially embody the patent even though it is technically incomplete. This prevents a patent owner from avoiding exhaustion merely by selling an essential component before routine completion of the claimed combination.

Quanta involved Intel microprocessors and chipsets sold under authority from LG Electronics. The products did not themselves include every part of the claimed computer systems. The Supreme Court nevertheless concluded that they embodied the essential features of the patented inventions and had no reasonable use other than incorporation into systems practicing the patents.

The same reasoning can apply to method claims. A patent owner cannot necessarily avoid exhaustion by drafting a claim as a process rather than a physical product. If an authorized product substantially embodies the method and its use practices the patented steps, the product's sale may exhaust the associated method claims.

This issue is particularly important for component suppliers, platform businesses, consumable products, and interconnected systems. You must compare the sold component with each asserted patent claim. A component with substantial independent uses may present a different result from a specialized component whose essential purpose is to practice the patent.

Patent Exhaustion, Licenses, and Post-Sale Restrictions

Calling a transaction a license does not automatically prevent exhaustion. Courts examine whether the arrangement authorizes a sale and whether the seller acted within its authority. The critical distinction is between a restriction on a licensee's authority to sell and a restriction imposed on a customer after an authorized sale.

A patent owner may give a licensee limited authority to manufacture or sell products. The license might restrict sales to a particular field, territory, customer group, or application. If the licensee sells outside that authority, the transaction may be unauthorized, and exhaustion may not protect the licensee or downstream parties. The precise language and the buyer's knowledge can matter.

By contrast, a patent owner that makes an authorized sale generally cannot preserve patent rights in the sold item merely by stating that the buyer may use it once or may not resell it. In Impression Products, Inc. v. Lexmark International, Inc., the Supreme Court held that Lexmark's single-use and no-resale conditions did not preserve patent infringement claims after the cartridges were sold.

A valid contract restriction may still create contractual rights against a party bound by it. That does not mean the patent rights revive or that every downstream purchaser becomes liable for infringement. Businesses should clearly identify the parties, licensed patents, permitted sales, fields of use, distribution rights, and remedies. A carefully drafted release clause may also help define which existing claims the parties intend to resolve. Available contract remedies, including requests for specific performance, depend on the agreement and governing law.

If your transaction mixes sales and licenses, contains field-of-use limits, involves foreign distribution, or raises questions about a component that substantially embodies patent claims, you can post your legal need on UpCounsel's marketplace. A patent attorney can review the claims, agreements, distribution chain, and controlling decisions, then revise the sales or licensing terms or assess infringement and contract exposure. Responses typically arrive within a day.

Authorized Foreign Sales and International Exhaustion

An authorized sale outside the United States can exhaust U.S. patent rights in the item sold. The Supreme Court confirmed this rule in Impression Products v. Lexmark. Lexmark had sold some patented printer cartridges abroad, and other businesses later acquired, refurbished, imported, and resold them in the United States. The Court held that an authorized foreign sale exhausted Lexmark's U.S. patent rights in those cartridges.

The location of the sale therefore does not, by itself, preserve U.S. patent control. A patent owner cannot rely solely on the fact that it received a different price abroad or did not intend the product to return to the United States. Once the patent owner authorizes the sale, U.S. patent law generally does not provide continuing control over that item.

Authorization remains essential. Impression Products does not protect counterfeit goods, products made without a license, or sales made beyond a licensee's authority. A foreign seller that never received permission from the U.S. patent owner may still create infringement risk when the goods enter the United States.

Contract and foreign-law questions may also remain. Distribution agreements can allocate territories, define customer groups, and impose obligations between contracting parties. Foreign patents are separate territorial rights, so a sale's consequences under another country's patent law may differ. Businesses planning parallel imports, international refurbishment, or cross-border resale should trace who manufactured the goods, who authorized each sale, and which parties agreed to territorial restrictions.

Comparing Sales, Licenses, and Restricted Transactions

The following table provides a practical starting point. It does not replace review of the patent claims or transaction documents, but it shows why the word used on an invoice or agreement rarely resolves the entire question.

Transaction May Patent Exhaustion Apply? Could Contract Issues Remain?
Patent owner makes an authorized sale Generally yes, for the particular item sold Yes, if the buyer accepted enforceable contractual duties
Licensee sells within its authority Generally yes, because the sale was authorized Yes, depending on the license and buyer agreement
Licensee or manufacturer makes an unauthorized sale Generally no, because authorization is missing Yes, including possible breach of the license
Transaction is a license rather than a sale Not automatically; the substance and scope require review Yes, the license defines the parties' permissions
Seller imposes a post-sale use or resale restriction An authorized sale generally exhausts patent rights despite the restriction Yes, against parties contractually bound by the restriction
Patent owner authorizes a foreign sale Yes, as to U.S. patent rights in the sold item Yes, and foreign patent law may require separate analysis

Several circumstances require closer review. These include transactions with no clear transfer of title, leases, licenses covering both products and services, sales by distributors with limited authority, bundled products, and components used in several systems. Refurbishing operations also require analysis when they replace the parts containing the patented features.

Patent exhaustion is not the same as exhaustion of administrative remedies. The latter generally concerns completing required agency procedures before seeking judicial review. The doctrines share the word "exhaustion," but they address different legal problems.

Patent Exhaustion vs. Patent Expiration

Patent exhaustion and patent expiration have different scopes. Exhaustion concerns patent rights in a particular item after an authorized sale. The patent itself remains in effect and can still be asserted against unauthorized making, selling, using, offering to sell, or importing other infringing products.

Expiration concerns the patent as a whole. When the enforceable patent term ends, the patent owner generally loses the patent-based right to exclude others from practicing the claimed invention. Expiration is not limited to one previously sold unit. Businesses should check the patent's status and relevant records rather than assuming that an older product is unprotected.

Use this decision checklist when evaluating a transaction:

  1. Identify the asserted patent and claims. Determine whether they cover the product, a component, a combination, or a method.
  2. Trace authorization. Identify the manufacturer, patent owner, licensees, distributors, and each sale in the chain.
  3. Classify the transaction. Determine whether it transferred ownership, granted possession temporarily, or provided a limited license.
  4. Review the license scope and restrictions. Separate limits on the seller's authority from obligations imposed on a buyer after sale.
  5. Evaluate the challenged conduct. Ask whether it involves using, reselling, or repairing the sold item, or instead making a new patented article.

Also consider patent misuse separately. Patent misuse is a defense involving an alleged improper attempt to broaden a patent's reach. Patent exhaustion may defeat a claim involving a sold item without establishing misuse. Likewise, an ineffective patent-based post-sale restriction may still raise a contract dispute. Keeping the doctrines separate helps identify the correct defense, potential remedy, and responsible party.

Frequently Asked Questions

When Does Patent Exhaustion Apply?

Patent exhaustion applies when the patent owner, or a seller acting within authorized licensing authority, sells an item covered by the patent. The analysis may require evidence such as manufacturing licenses, invoices, distribution agreements, and ownership records. If the chain contains an unauthorized manufacturer or an out-of-scope sale, a downstream buyer should not assume that ordinary possession proves exhaustion.

What Is Patent Exhaustion in a Resale Dispute?

Patent exhaustion is a defense that can prevent a patent owner from treating resale of an authorized product as infringement. A reseller should preserve documents showing where the goods came from and that they are genuine. Those records can be decisive when the patent owner alleges that the inventory includes counterfeit units, unauthorized imports, or products made outside a license.

What Is Patent Exhaustion and When Does It Apply to Method Claims?

Patent exhaustion can limit enforcement of method claims when an authorized product substantially embodies the patented process. The result depends on the relationship between the product and claimed steps. A multipurpose product may present a weaker exhaustion argument than specialized equipment designed to perform the method without additional inventive activity.

What Are the Benefits of the Exhaustion Doctrine?

The doctrine gives buyers greater certainty that they can transfer and use items they legitimately own without obtaining repeated patent permission. It also supports repair, refurbishment, used-goods sales, and ordinary distribution. Patent owners still retain meaningful protection because exhaustion does not authorize counterfeit manufacturing, unlicensed production, or creation of new patented copies.

Can I Sell Patented Items That I Bought?

Yes, you can generally sell genuine patented items acquired through an authorized sale. Before selling large quantities, confirm the source and keep purchase records, especially for imported or refurbished inventory. If your process combines units, replaces patented components, or creates additional finished products, review whether the activity remains resale or repair rather than new manufacturing.

Is Trying to Control a Sold Product Patent Abuse?

Not necessarily, because patent misuse, unenforceable post-sale patent control, and breach of contract are separate issues. A restriction might fail as a basis for patent infringement without making the patent permanently unenforceable or invalidating the underlying contract. The correct result depends on the restriction, the parties bound by it, and the remedy the patent owner seeks.